Status: Recruiting
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
This is a double-blind, randomized, two-period crossover study to evaluate the efficacy and safety of a single oral dose of tasimelteon and matching placebo in male and female subjects with DSWPD and the CRY1Δ11 variant.
Participants needed: 60
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Vanda PharmaceuticalsUpdated: Nov 22, 2024Locations: 1
Eligibility criteria
Ability and acceptance to provide written informed consent. [+4]
Major surgery, trauma, illness, general anesthesia, or immobility for 3 or more... [+3]